Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current HIV Research
  4. Volume 22, Issue 5
  5. Article
Volume 22, Issue 5
  • ISSN: 1570-162X
  • E-ISSN: 1873-4251

Abstract

The aim of the present investigation is to identify effective anti-HIV drugs through the virtual screening of the coumarin pharmacophore with or without substituents. Virtual screening started with target identification through computation docking and interactions, binding affinity through molecular dynamics, and the ADMET profile through the use of various enzymes. The target study suggests that the target is involved in various stages of HIV replication and in determining the ways in which non-nucleoside reverse transcriptase inhibitors (RTIs) influence it. The interaction pattern and simulation study conclude the specific affinity of coumarin pharmacophore to the HIV's reverse transcriptase enzyme, especially 3HVT. Moreover, the amide linkage worked as a synergistic bridge to provide more interaction to the pharmacophore. The initial results led to the determination of 83 virtual amide-like molecules, which were screened through docking and MD studies (100 ns) on the best-suited enzyme HIV's reverse transcriptase enzyme, such as PDB ID “3HVT”. The virtual screening study revealed the high affinity of compounds 7d and 7e with the lowest IC values of 0.729 and 0.658 μM; moreover, their metabolism pattern study, toxicity, and QED values in a range of 0.31-0.40 support a good drug candidate. The two compounds were also synthesized and characterized for future and studies. The -based descriptor of compounds 7d and 7e indicates the potential future and provides the best two molecules and their synthetic route for the development of a more effective drug to combat HIV/AIDS epidemics.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/chr/10.2174/011570162X308550240821074309
2024-09-23
2025-01-10

  • From This Site

    /content/journals/chr/10.2174/011570162X308550240821074309
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. CoffinJ. HaaseA. LevyJ.A. Human immunodeficiency viruses.Science19862324751697710.1126/science.3008335 3008335
     [Google Scholar]
  2. KallingsL.O. The first postmodern pandemic: 25 years of HIV/AIDS.J. Intern. Med.2008263321824310.1111/j.1365‑2796.2007.01910.x 18205765
     [Google Scholar]
  3. van SchalkwykC. MahyM. JohnsonL.F. Imai-EatonJ.W. Updated data and methods for the 2023 UNAIDS HIV estimates.J. Acquir. Immune Defic. Syndr.2024951Se1e410.1097/QAI.0000000000003344 38180734
     [Google Scholar]
  4. NyamweyaS. HegedusA. JayeA. Rowland-JonesS. FlanaganK.L. MacallanD.C. Comparing HIV‐1 and HIV‐2 infection: Lessons for viral immunopathogenesis.Rev. Med. Virol.201323422124010.1002/rmv.1739 23444290
     [Google Scholar]
  5. DalgleishA.G. BeverleyP.C.L. ClaphamP.R. CrawfordD.H. GreavesM.F. WeissR.A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.Nature1984312599676376710.1038/312763a0 6096719
     [Google Scholar]
  6. SinghS.K. SiddhantaA. Whether HIV discordance among couples is getting altered due to the changing discourse of the HIV epidemic in India? Evidence from two rounds of national Family Health survey.J. Health Manag.202325226327110.1177/09720634231175577
     [Google Scholar]
  7. PachuauL.N. TannousC. ChawngthuR.L. AghoK.E. HIV and its associated factors among people who inject drugs in Mizoram, Northeast India.PLoS One2023185e028600910.1371/journal.pone.0286009 37216389
     [Google Scholar]
  8. HemelaarJ. ElangovanR. YunJ. Global and regional molecular epidemiology of HIV-1, 1990–2015: A systematic review, global survey, and trend analysis.Lancet Infect. Dis.201919214315510.1016/S1473‑3099(18)30647‑9 30509777
     [Google Scholar]
  9. BasoulisD. MastrogianniE. VoutsinasP.M. PsichogiouM. HIV and COVID-19 co-infection: Epidemiology, clinical characteristics, and treatment.Viruses202315257710.3390/v15020577 36851791
     [Google Scholar]
  10. MittalR.K. AggarwalM. KhatanaK. PurohitP. Quinoline: Synthesis to application.Med. Chem.20221913146 35240965
     [Google Scholar]
  11. MittalR.K. PurohitP. Quinoline-3-carboxylic acids: A step toward highly selective antiproliferative agent.Anticancer. Agents Med. Chem.2021211317081716
     [Google Scholar]
  12. JadhavarP.S. Sustainable approaches towards the synthesis of quinoxalines.Green Chem Synth Bioact Heterocycl20142014376710.1007/978‑81‑322‑1850‑0_2
     [Google Scholar]
  13. McKeeT.C. CovingtonC.D. FullerR.W. Pyranocoumarins from tropical species of the genus Calophyllum: A chemotaxonomic study of extracts in the National Cancer Institute collection.J. Nat. Prod.199861101252125610.1021/np980140a 9784162
     [Google Scholar]
  14. BuckheitR.W.Jr WhiteE.L. Fliakas-BoltzV. Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide.Antimicrob. Agents Chemother.19994381827183410.1128/AAC.43.8.1827 10428899
     [Google Scholar]
  15. UpadhyayR.K. Anti-HIV natural products from medicinal plants: A review.Int J Green Pharm2023171
     [Google Scholar]
  16. HuangL. KashiwadaY. CosentinoL.M. FanS. LeeK-H. 3′,4′-Di-o-(−)-camphanoyl-(+)-ciskhellactone and related compounds: A. new class of potent anti-HIV agents.Bioorg. Med. Chem. Lett.19944459359810.1016/S0960‑894X(01)80161‑X
     [Google Scholar]
  17. YuD. SuzukiM. XieL. Morris-NatschkeS.L. LeeK.H. Recent progress in the development of coumarin derivatives as potent anti‐HIV agents.Med. Res. Rev.200323332234510.1002/med.10034 12647313
     [Google Scholar]
  18. LeonardJ.T. RoyK. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.Eur. J. Med. Chem.2008431819210.1016/j.ejmech.2007.02.021 17452064
     [Google Scholar]
  19. BeyerA. LawtrakulL. PungpoP. WolschannP. Structural aspects of non-nucleoside HIV-1 reverse transcriptase inhibition.Curr. Computeraided Drug Des.2007328710010.2174/157340907780809507
     [Google Scholar]
  20. IşıkA. ÇevikU.A. CelikI. Synthesis, characterization, molecular docking, dynamics simulations, and in silico absorption, distribution, metabolism, and excretion (ADME) studies of new thiazolylhydrazone derivatives as butyrylcholinesterase inhibitors.Z. Naturforsch. C J. Biosci.20227711-1244745710.1515/znc‑2021‑0316 35599239
     [Google Scholar]
  21. IşıkA. Acar ÇevikU. KarayelA. Synthesis, DFT calculations, in silico studies, and antimicrobial evaluation of benzimidazole-thiadiazole derivatives.ACS Omega2024916184691847910.1021/acsomega.4c00543 38680334
     [Google Scholar]
  22. FuchsD.I. SerioL.D. BalajiS. SprengerK.G. Investigating how HIV-1 antiretrovirals differentially behave as substrates and inhibitors of P-glycoprotein via molecular dynamics simulations.Comput. Struct. Biotechnol. J.2024232669267910.1016/j.csbj.2024.06.025 39027651
     [Google Scholar]
  23. KumarV. PandeyI.P. JainJ. TripathiR.B. One step towards: The synthesis of optimized coumarin derivatives as an anti-HIV Agent.Indian J Pharmaceut Educat Res2019534ss624s62910.5530/ijper.53.4s.158
     [Google Scholar]
  24. MaheswaraM. SiddaiahV. DamuG.L.V. RaoY.K. RaoC.V. A solvent-free synthesis of coumarins via Pechmann condensation using heterogeneous catalyst.J. Mol. Catal. Chem.20062551-2495210.1016/j.molcata.2006.03.051
     [Google Scholar]
  25. DittmerD.C. LiQ. AvilovD.V. Synthesis of coumarins, 4-hydroxycoumarins, and 4-hydroxyquinolinones by tellurium-triggered cyclizations.J. Org. Chem.200570124682468610.1021/jo050070u 15932305
     [Google Scholar]
  26. KhalymbadzhaI.A. FatykhovR.F. ButorinI.I. bioinspired pyrano[2,3-f]chromen-8-ones: Ring C-opened analogues of calanolide A: Synthesis and anti-HIV-1 evaluation.Biomimetics2024914410.3390/biomimetics9010044 38248618
     [Google Scholar]
  27. ZekiN.M. MustafaY.F. Coumarin hybrids: a sighting of their roles in drug targeting.Chem. Zvesti202478105753577210.1007/s11696‑024‑03498‑z
     [Google Scholar]
  28. DoucetC. PochetL. ThierryN. PirotteB. DelargeJ. Reboud-RavauxM. 6-Substituted 2-oxo-2H-1-benzopyran-3-carboxylic acid as a core structure for specific inhibitors of human leukocyte elastase.J. Med. Chem.199942204161417110.1021/jm990070k 10514286
     [Google Scholar]
/content/journals/chr/10.2174/011570162X308550240821074309
Loading
A Step Towards Optimization of Amide-Linked Coumarin Pharmacophore: As an Anti-HIV Agent
Current HIV Research 22, 279 (2024); https://doi.org/10.2174/011570162X308550240821074309
/content/journals/chr/10.2174/011570162X308550240821074309
/content/journals/chr/10.2174/011570162X308550240821074309
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

file format download Download

  • Article Type:     Review Article
Keyword(s): coumarins; HIV integrase inhibitors; HIV/AIDS; protease inhibitors (PI); QSAR; Reverse transcriptase inhibitors (RTI)
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test